US 9249227
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9249227 (Use of semaphorin-4D binding molecules for treating neurodegenerative disorders) held by VACCINEX, INC. expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P